 SAN DIEGO, Feb. 4, 2022 PRNewswire -- Kintara Therapeutics, Inc. Nasdaq: KTRA, a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its President and Chief Executive Officer, Robert E. Hoffman will present a corporate overview at the BIO CEO Investor Conference, which is being held on February 14 17, 2022 at the New York Marriott Marquis in New York City, NY. 